Dynamic changes, cut-off points, sensitivity, and specificity of laboratory data to differentiate macrophage activation syndrome from active disease

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Assari, Raheleh ^a   Ziaee, Vahid ^b   Mirmohammadsadeghi, Arash ^b   Moradinejad, Mohammad Hassan ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FERRITIN; LACTATE DEHYDROGENASE; LIVER ENZYME; METHYLPREDNISOLONE; SERUM ALBUMIN; SODIUM;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; BILIRUBIN BLOOD LEVEL; BLEEDING DISORDER; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; EARLY DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HEMOPHAGOCYTIC SYNDROME; HUMAN; INTERNATIONAL NORMALIZED RATIO; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LIVER DYSFUNCTION; MACROPHAGE ACTIVATION SYNDROME; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PANCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; BLOOD; BLOOD ANALYSIS; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; INFANT; STANDARDS;

ADOLESCENT; ARTHRITIS, JUVENILE; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SENSITIVITY AND SPECIFICITY;

EID: 84929340663     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/424381     Document Type: Article

References (32)

1. A.-M. Prieur and J. L. Stephan, "Macrophage activation syndrome in children with joint disease", Revue du Rhumatisme-English Edition, vol. 61, pp. 385-388, 1994.
2. A. Parodi, S. Davì, A. B. Pringe et al., "Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients", Arthritis & Rheumatism, vol. 60, no. 11, pp. 3388-3399, 2009.
3. G. A. Latino, C. Manlhiot, R. S. M. Yeung, N. Chahal, and B. W. McCrindle, "Macrophage activation syndrome in the acute phase of Kawasaki disease", Journal of Pediatric Hematology/Oncology, vol. 32, no. 7, pp. 527-531, 2010.
4. G. Simonini, I. Pagnini, L. Innocenti, G. B. Calabri, M. De Martino, and R. Cimaz, "Macrophage activation syndrome/hemophagocytic lymphohistiocytosis and Kawasaki disease", Pediatric Blood & Cancer, vol. 55, no. 3, pp. 592-592, 2010.
5. D. Rigante, E. Capoluongo, B. Bertoni et al., "First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome", Arthritis and Rheumatism, vol. 56, no. 2, pp. 658-661, 2007.
6. L. Rossi-Semerano, B. Hermeziu, M. Fabre, and I. Koné-Paut, "Macrophage activation syndrome revealing familial mediterranean fever", Arthritis Care and Research, vol. 63, no. 5, pp. 780-783, 2011.
7. M. H. Moradinejad and V. Ziaee, "Theincidence ofmacrophage activation syndrome in children with rheumatic disorders", Minerva Pediatrica, vol. 63, no. 6, pp. 459-466, 2011.
8. A. Ravelli, S. Magni-Manzoni, A. Pistorio et al., "Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis", Journal of Pediatrics, vol. 146, no. 5, pp. 598-604, 2005.
9. A. Ravelli and A. Martini, "Macrophage activation syndrome", in Pediatric Rheumatology, T. H. Lehman and R. Cimaz, Eds., pp. 55-63, Elsevier, Amsterdam, The Netherlands, 2008.
10. B. H. Athreya, "Is macrophage activation syndrome a new entity?" Clinical and Experimental Rheumatology, vol. 20, no. 2, pp. 121-123, 2002.
11. A. V. Ramanan and R. Schneider, "Macrophage activation syndrome-what's in a name!", Journal of Rheumatology, vol. 30, no. 12, pp. 2513-2516, 2003.
12. A. Ravelli, A. A. Grom, E. M. Behrens, and R. Q. Cron, "Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment", Genes and Immunity, vol. 13, no. 4, pp. 289-298, 2012.
13. S. W. Canna, A. A. De Jesus, S. Gouni et al., "An activating NLRC4 inflammasomemutation causes autoinflammation with recurrent macrophage activation syndrome", Nature Genetics, vol. 46, no. 10, pp. 1140-1146, 2014.
14. Y. Wang, Z. Wang, J. Zhang et al., "Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood", PLoS ONE, vol. 9, no. 9, Article IDe107386, 2014.
15. J.-I. Henter, A. Horne, M. Aricó et al., "HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis", Pediatric Blood and Cancer, vol. 48, no. 2, pp. 124-131, 2007.
16. S. Davì, A. Consolaro, D. Guseinova et al., "An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis", Journal of Rheumatology, vol. 38, no. 4, pp. 764-768, 2011.
17. S. Davi, B. Lattanzi, E. Demirkaya et al., "Toward the development of new diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis", Annals of Paediatric Rheumatology, vol. 1, no. 1, pp. 1-7, 2012.
18. K. Lehmberg, I. Pink, C. Eulenburg, K. Beutel, A. Maul-Pavicic, and G. Janka, "Differentiatingmacrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis", Journal of Pediatrics, vol. 162, no. 6, pp. 1245-1251, 2013.
19. A. Parodi, S. Davì, A. B. Pringe et al., "Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients", Arthritis and Rheumatism, vol. 60, no. 11, pp. 3388-3399, 2009.
20. R. E. Petty, T. R. Southwood, P. Manners et al., "International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001", Journal of Rheumatology, vol. 31, no. 2, pp. 390-392, 2004.
21. J. W. Newburger, M. Takahashi, M. A. Gerber et al., "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association", Circulation, vol. 110, no. 17, pp. 2747-2771, 2004.
22. M. C. Hochberg, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis and rheumatism, vol. 40, no. 9, p. 1725, 1997.
23. T. Beukelman, N. M. Patkar, K. G. Saag et al., "2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features", Arthritis Care & Research, vol. 63, no. 4, pp. 465-482, 2011.
24. M. Bandeira, S. Buratti, M. Bartoli et al., "Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus", Lupus, vol. 15, no. 8, pp. 515-520, 2006.
25. S. H. Park, J. M. Goo, and C.-H. Jo, "Receiver operating characteristic (ROC) curve: practical review for radiologists", Korean Journal of Radiology, vol. 5, no. 1, pp. 11-18, 2004.
26. M. M. Kostik, M. F. Dubko, V. V. Masalova et al., "Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis", Seminars in Arthritis & Rheumatism, vol. 44, no. 4, pp. 417-422, 2015.
27. R. F. Ritchie, G. E. Palomaki, L. M. Neveux, O. Navolotskaia, T. B. Ledue, and W. Y. Craig, "Reference distributions for the negative acute-phase serum proteins, albumin, transferrin, and transthyretin: a practical, simple and clinically relevant approach in a large cohort", Journal of Clinical Laboratory Analysis, vol. 13, no. 6, pp. 273-279, 1999.
28. F. D. Benedetti and R. Schneider, "Systemic juvenile idiopathic arthritis", in Textbook of Clinical Rheumatology, J. T. Cassidy, R. E. Petty, R. M. Laxer, and C. B. Lindsley, Eds., pp. 236-248, Elsevier, Toronto, Canada, 2011.
29. C. Rosário, G. Zandman-Goddard, E. G. Meyron-Holtz, D. P. D'Cruz, and Y. Shoenfeld, "The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome", BMC Medicine, vol. 11, no. 1, article 185, 2013.
30. M. B. Pepys and G. M. Hirschfield, "C-reactive protein: a critical update", Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805-1812, 2003.
31. S. Kounami, M. Yoshiyama, K. Nakayama et al., "Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis", Acta Haematologica, vol. 113, no. 2, pp. 124-129, 2005.
32. K. Yamazawa, K. Kodo, J. Maeda et al., "Hyponatremia, hypophosphatemia, and hypouricemia in a girl with macrophage activation syndrome", Pediatrics, vol. 118, no. 6, pp. 2557-2560, 2006.